|
US 11,753,366 B2 |
|
| Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors |
| Jiping Fu, Danville, CA (US); Yan Lou, Dallas, TX (US); and Yigang He, Newark, DE (US) |
| Assigned to NIKANG THERAPEUTICS, INC., Wilmington, DE (US) |
| Filed by NIKANG THERAPEUTICS, INC., Wilmington, DE (US) |
| Filed on Feb. 11, 2022, as Appl. No. 17/670,423. |
| Application 17/670,423 is a continuation of application No. 17/218,129, filed on Mar. 30, 2021, granted, now 11,267,782. |
| Application 17/218,129 is a continuation of application No. 16/851,018, filed on Apr. 16, 2020, abandoned. |
| Claims priority of provisional application 62/946,191, filed on Dec. 10, 2019. |
| Claims priority of provisional application 62/836,019, filed on Apr. 18, 2019. |
| Prior Publication US 2022/0162158 A1, May 26, 2022 |
| Int. Cl. C07D 213/63 (2006.01); C07D 213/65 (2006.01); C07C 255/54 (2006.01); C07C 255/50 (2006.01); C07C 313/06 (2006.01); A61P 35/00 (2006.01); A61P 1/16 (2006.01); A61P 9/12 (2006.01); A61P 29/00 (2006.01); A61K 45/06 (2006.01); A61K 31/277 (2006.01); A61K 31/4412 (2006.01); C07D 233/60 (2006.01) |
